Skip to main content
. 2022 Jun 1;13:877807. doi: 10.3389/fendo.2022.877807

Figure 2.

Figure 2

Identification of metabolites in tryptophan-kynurenine pathway associated with PCOS. (A) Unadjusted odds ratios (95% CIs) of PCOS per 1 SD change in plasma abundance of each metabolite. (B) The odds ratios (95% CIs) of PCOS per 1 SD increase in plasma abundance of each metabolite adjusted for baseline age, BMI, LH, androstenedione, and AMH. (C, D) Concentration-effect relationship of metabolites in tryptophan-kynurenine pathway associated with PCOS. The prevalence of PCOS was dramatically raised with the quartiles of TRP, tryptophan; KYN, kynurenine; KYNA,kynurenic acid and QA, quinolinic acid while decreased with quartiles of KYN/KYNA, before (C) and after (D) adjusting for baseline age, BMI, LH, androstenedione and AMH.